Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

Pfizer36 enrolled

Overview

This trial evaluates whether long-term treatment with Genotropin normalizes final (adult) height in short children born small for gestational age

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Growth Disorder

Interventions

Treatment with Genotropin in different dosagesDRUG

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Participation in the 90-080 study Exclusion Criteria: * Any severe, acute or chronic disease * Any other identifiable reason for short stature

Outcomes

Primary Outcomes

Final height, compared to the expected familial target height

Secondary Outcomes

Body weight, body mass index at final height; adverse events and assessment of hematological and clinical chemistry

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.